Suppr超能文献

贝斯特蛋白病

Bestrophinopathies

作者信息

MacDonald Ian M, Lee Thomas, Lawrence Jessica

机构信息

Department of Ophthalmology University of Alberta, Edmonton, Alberta, Canada

Department of Ophthalmology University of Ottawa, Ottawa, Ontario, Canada

Abstract

CLINICAL CHARACTERISTICS

Bestrophinopathies, the spectrum of ophthalmic disorders caused by pathogenic variants in , are typically characterized by retinal degeneration. The four recognized phenotypes are the three autosomal dominant disorders: Best vitelliform macular dystrophy (BVMD), adult-onset vitelliform macular dystrophy (AVMD), and autosomal dominant vitreoretinochoroidopathy (ADVIRC); and autosomal recessive bestrophinopathy (ARB). Onset is usually in the first decade (except AVMD in which onset is age 30 to 50 years). Slow visual deterioration is the usual course. Choroidal neovascularization can occur in rare cases. ADVIRC is also associated with panophthalmic involvement including nanophthalmos, microcornea, hyperopia, and narrow anterior chamber angle with angle closure glaucoma.

DIAGNOSIS/TESTING: The diagnosis of autosomal dominant bestrophinopathy is established in a proband with suggestive findings and a heterozygous pathogenic (or likely pathogenic) variant identified by molecular genetic testing. The diagnosis of autosomal recessive bestrophinopathy is established in a proband with suggestive findings and biallelic pathogenic variants.

MANAGEMENT

For individuals with significant visual impairment, referral to a low vision clinic; attention to special education needs for children with visual impairment; and occupational counseling. Regarding advanced BVMD fundus lesions, no clinical trials have compared conservative treatment vs laser photocoagulation for choroidal neovascularization (CNV) and hemorrhage. Also, there are no ongoing clinical trials regarding the effectiveness of treatment with anti-VEGF (vascular endothelial growth factor) agents. Annual ophthalmologic examination (including best corrected visual acuity, visual fields, and spectral domain optical coherence tomography) to monitor progression of fundus lesions and to evaluate for coincidental development of CNV; in childhood, perform annual ophthalmologic examinations to help prevent the development of amblyopia. Cessation of smoking to help prevent neovascularization of the retina. It is appropriate to clarify the genetic status of apparently asymptomatic older and younger at-risk relatives of an affected individual in order to identify as early as possible those who would benefit from prompt ophthalmologic evaluation and routine follow up.

GENETIC COUNSELING

BVMD, AVMD, and ADVIRC are inherited in an autosomal dominant (AD) manner. By definition, autosomal recessive bestrophinopathy (ARB) is inherited in an autosomal recessive (AR) manner. AD bestrophinopathy. Each child of an affected individual has a 50% chance of inheriting the pathogenic variant. AR bestrophinopathy. If both parents are known to be heterozygous for a pathogenic variant, each sib of an affected individual has at conception a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Once the pathogenic variant(s) have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic testing for a bestrophinopathy are possible.

摘要

临床特征

Bestrophinopathy相关疾病是由 基因的致病变异引起的一系列眼科疾病,其典型特征为视网膜变性。已确认的四种表型为三种常染色体显性疾病:Best卵黄样黄斑营养不良(BVMD)、成人型卵黄样黄斑营养不良(AVMD)和常染色体显性玻璃体视网膜脉络膜病变(ADVIRC);以及常染色体隐性Bestrophinopathy(ARB)。发病通常在第一个十年(AVMD除外,其发病年龄为30至50岁)。视力通常呈缓慢下降。罕见情况下可发生脉络膜新生血管。ADVIRC还与全眼球受累有关,包括小眼球、小角膜、远视以及伴有闭角型青光眼的前房角狭窄。

诊断/检测:常染色体显性Bestrophinopathy的诊断基于先证者具有提示性发现,且通过分子遗传学检测鉴定出杂合致病变异(或可能的致病变异)。常染色体隐性Bestrophinopathy的诊断基于先证者具有提示性发现且存在双等位基因致病变异。

管理

对于有明显视力损害的个体,转诊至低视力诊所;关注视力受损儿童的特殊教育需求;以及职业咨询。关于晚期BVMD眼底病变,尚无临床试验比较保守治疗与激光光凝治疗脉络膜新生血管(CNV)和出血的效果。此外,目前也没有关于抗血管内皮生长因子(VEGF)药物治疗有效性的正在进行的临床试验。每年进行眼科检查(包括最佳矫正视力、视野和光谱域光学相干断层扫描)以监测眼底病变进展并评估CNV的并发情况;在儿童期,每年进行眼科检查以帮助预防弱视的发生。戒烟以帮助预防视网膜新生血管。明确受影响个体明显无症状的老年和年轻高危亲属的基因状况,以便尽早识别那些将从及时的眼科评估和常规随访中受益的人是合适的。

遗传咨询

BVMD、AVMD和ADVIRC以常染色体显性(AD)方式遗传。根据定义,常染色体隐性Bestrophinopathy(ARB)以常染色体隐性(AR)方式遗传。AD型Bestrophinopathy。受影响个体的每个孩子有50%的机会继承致病变异。AR型Bestrophinopathy。如果已知父母双方均为某一致病变异的杂合子,则受影响个体的每个同胞在受孕时有25%的机会受影响,50%的机会为无症状携带者,25%的机会未受影响且不是携带者。一旦在受影响的家庭成员中鉴定出致病变异,则对于风险增加的妊娠可进行产前检测,对于Bestrophinopathy可进行植入前基因检测。

相似文献

2
Typical best vitelliform dystrophy secondary to biallelic variants in BEST1.
Ophthalmic Genet. 2024 Feb;45(1):38-43. doi: 10.1080/13816810.2023.2188227. Epub 2023 Mar 13.
3
The Retinal Phenotype Associated with the p.Pro101Thr BEST1 Variant.
Ophthalmol Retina. 2024 Mar;8(3):288-297. doi: 10.1016/j.oret.2023.09.012. Epub 2023 Sep 16.
4
associated bestrophinopathies with angle closure and post-surgical malignant glaucoma.
Ophthalmic Genet. 2024 Dec;45(6):571-582. doi: 10.1080/13816810.2024.2398827. Epub 2024 Sep 11.
6
The Clinical Features and Genetic Spectrum of a Large Cohort of Chinese Patients With Vitelliform Macular Dystrophies.
Am J Ophthalmol. 2020 Aug;216:69-79. doi: 10.1016/j.ajo.2020.03.047. Epub 2020 Apr 9.
8
Association of Clinical and Genetic Heterogeneity With BEST1 Sequence Variations.
JAMA Ophthalmol. 2020 May 1;138(5):544-551. doi: 10.1001/jamaophthalmol.2020.0666.
9
Disease expression caused by different variants in the BEST1 gene: genotype and phenotype findings in bestrophinopathies.
Acta Ophthalmol. 2022 May;100(3):e847-e858. doi: 10.1111/aos.14958. Epub 2021 Jul 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验